Company Overview and News

0
Should John Hancock Multifactor Large Cap ETF (JHML) Be on Your Investing Radar?

2018-06-20 zacks
Launched on 09/28/2015, the John Hancock Multifactor Large Cap ETF (JHML - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity market.
IVV IVV JHML

213
CenturyLink Is A Great Value Play That Pays You 12% To Wait

2018-06-18 seekingalpha
There is light at the end of the tunnel because of new leadership, commitment to the dividend, and a new profit growth engine.
STT IVV BLK STT.PRC STT.PRE STT.PRD VRX STT.PRG CTL VYM IVV

158
Should First Trust Capital Strength ETF (FTCS) Be on Your Investing Radar?

2018-06-14 zacks
Looking for broad exposure to the Large Cap Blend segment of the US equity market? You should consider the First Trust Capital Strength ETF (FTCS - Free Report) , a passively managed exchange traded fund launched on 07/06/2006.
EXPD IVV AAPL IVV

12
Should PowerShares Russell 1000 Equal Weight Portfolio (EQAL) Be on Your Investing Radar?

2018-06-13 zacks
Launched on 12/23/2014, the PowerShares Russell 1000 Equal Weight Portfolio (EQAL - Free Report) is a passively managed exchange traded fund designed to provide a broad exposure to the Large Cap Blend segment of the US equity market.
PBF IVV WLL EQAL HFC IVV

0
What To Do When ETFs Become Weapons Of Mass Destruction?

2018-06-10 seekingalpha
Popular cap-weighted mega ETFs are sometimes called weapons of mass destruction because of the systemic risks they pose.
IVV IVV VFLQ

33
What Sectors And Stocks Have ETFs Been Buying?

2018-06-08 seekingalpha
Gold-backed ETF holdings added 72.2 tons to 2,481 tons in April which is the strongest month of net inflows in more than a year.
MAT IVV TRV HAS CINF IVV IEFA

23
May ETF Asset Report: U.S. Equities Rule

2018-05-31 zacks
Geopolitical tensions, oil price movement and President Trump’s announcements hit the headlines in the month of May. Donald Trump made impactful announcements pertaining to deregulations, trade relations with other countries and sanctions against countries like Iran and Venezuela. Overall, markets remained upbeat barring some occasional dips.
AGG IVV ELY QQQ IEF VOO SPY EZU IVV IWM EEM

6
Is iShares Core Aggressive Allocation ETF (AOA) a Hot ETF Right Now?

2018-05-31 zacks
The iShares Core Aggressive Allocation ETF (AOA - Free Report) was launched on 11/04/2008, and is a smart beta exchange traded fund designed to offer broad exposure to the Total Portfolio ETFs category of the U.S. equity market.
AOA IMMR ALIMR IVV IVV

108
Is SPDR Russell 1000 Momentum Focus ETF (ONEO) a Hot ETF Right Now?

2018-05-18 zacks
Making its debut on 12/02/2015, smart beta exchange traded fund SPDR Russell 1000 Momentum Focus ETF (ONEO - Free Report) provides investors broad exposure to the Large Cap ETFs category of the U.S. equity market.
IVV LEA MU ONEO JSC JPP IVV

6
Should JPMorgan Diversified Return U.S. Equity ETF (JPUS) Be on Your Investing Radar?

2018-05-15 zacks
If you're interested in broad exposure to the Large Cap Blend segment of the US equity market, look no further than the JPMorgan Diversified Return U.S. Equity ETF (JPUS - Free Report) , a passively managed exchange traded fund launched on 09/29/2015.
IVV GD JPUS CSX IVV EXC

41
Week 20 Breakout Forecast: Short-Term Picks To Give You An Edge

2018-05-14 seekingalpha
Publishing 2 of the 8 new Week 20 breakout stocks that are available only to subscribers with better than 10% short-term upside potential.
IVV QQQ KTOS NVTA IVV

188
Big U.S. Stocks' Q1'18 Fundamentals

2018-05-12 seekingalpha
The big US stocks’ latest quarterly results proved amazingly good. Sales and profits both rocketed higher as extreme stock-market optimism and big-corporate-tax-cut hopes fueled massive spending.
IBM BRK.A HD IVV GE VOO ABBV IVV BA DWDP MO

190
U.S. Weekly FundFlows Insight Report: Weekly Equity Fund Flows Turn Negative Despite The Up Market

2018-05-11 seekingalpha
For the third week in a row, investors were net purchasers of fund assets (including those of conventional funds and ETFs), taking in a little more than $8.2 billion. Despite market gains during the week, fund investors were net redeemers of equity funds (-$231 million) while being net purchasers of money market funds (+$8.2 billion), municipal bond funds (+$167 million), and taxable bond funds (+$86 million) for the fund-flows week ended May 9, 2018.
BRK.A IVV QQQ AAPL IVV SCHO IWM SHY EEM

2
Is iShares Core Conservative Allocation ETF (AOK) a Hot ETF Right Now?

2018-05-08 zacks
Launched on 11/04/2008, the iShares Core Conservative Allocation ETF (AOK - Free Report) is a smart beta exchange traded fund offering broad exposure to the Total Portfolio ETFs category of the U.S. equity market.
IVV IVV AOK

67
Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?

2018-05-02 zacks
Looking for broad exposure to the Large Cap Blend segment of the US equity market? You should consider the SPDR Russell 1000 Low Volatility Focus ETF (ONEV - Free Report) , a passively managed exchange traded fund launched on 12/02/2015.
WFC WFCNP SYY WFC.WS ONEV WFC.PRL WFC.PRJ JSC BAX WFC.PRT IVV WFC.PRR WFC.PRQ WFC.PRP WFC.PRO EQR WFC.PRN JPP IVV WFC.PRY WFC.PRX WFC.PRW WFC.PRV

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to ASX:IVV / ISHARES CORE S&P 500 ETF on message board site Silicon Investor.

Avino Silver u0026 Gold Mines Ltd. (ASM.V)